Form 4: Abeona Therapeutics Director Eric Crombez Acquires Shares
SEC Form 4 Filing
Director Eric Crombez acquired 11,044 shares of Abeona Therapeutics common stock on August 13, 2024.
Summary
- On August 13, 2024, Eric Crombez, a director of Abeona Therapeutics Inc., acquired 11,044 shares of common stock.
- The shares were acquired at a price of $0.00.
- Following the transaction, Crombez directly owns 11,044 shares of Abeona Therapeutics.
- The restricted stock will vest on August 13, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The acquisition of shares by a director could be interpreted as a positive sign, but without further context, it's difficult to gauge the overall impact.
Positives
- A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider transactions and provides limited insight into broader industry trends.
Stakeholder Impact
- Shareholders may view the director's share acquisition as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Date of transaction: Eric Crombez acquired 11,044 shares of common stock. |
| 08/13/2025 | Vesting date for the restricted stock. |
| 08/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.